Human Technopole’s research is based on a mix of fundamental and translational research. We will host extensive core expertise in basic research in areas relevant for the understanding of human biology and physiology.
Translational and more medically oriented research, on the other hand, will be conducted largely in collaboration with external organisations, including clinical research and industrial partners.
Our contribution to human health is a comprehensive and interdisciplinary approach to the study of human biology, aimed at understanding the basic mechanisms that regulate physiology and disease, to help tackle some of the most relevant challenges to human health.
Collectively, Human Technopole’s research work will advance our understanding and help develop novel therapeutic strategies for various disease groups, including some chronic and degenerative diseases.
Five broad, complementary and highly relevant areas for biomedical and health-related research have been selected to form the basis for Human Technopole’s research strategy in the upcoming years: Genomics, Neurogenomics, Structural Biology, Computational Biology and a focus on public health and healthcare systems with the Centre for Analysis, Decisions & Society, a joint collaboration with Politecnico di Milano.
The Human Technopole campus features state-of-the-art infrastructure and facilities. Our facilities are open and available to HT scientists and researchers as well as the external scientific community who are able to access them through open selection procedures based on merit. We are currently setting up six research facilities:
Cryo-Electron Microscopy Facility
Light Microscopy Imaging Facility
Image Analysis Facility
Automated Stem Cell and Organoid Facility
In addition to these, further technological platforms and Core Facilities will be available to Human Technopole’s scientists, including Fluorescence Activated Cell Sorting service, Protein Expression and Purification, Crystallisation and Biophysics, Proteomics, Metabolomics, Reprogramming, Editing and Organoid Culture, Animal Research Facility and Transgenic Facility.
Our first facilities will open in 2021. Following their opening, we will be sharing the rules for accessing our infrastructures with the national scientific community.